KeyBanc Reiterates Their Buy Rating on Athenahealth

By Carrie Williams

KeyBanc analyst Brent Bracelin reiterated a Buy rating on Athenahealth (NASDAQ: ATHN) yesterday and set a price target of $152. The company’s shares closed yesterday at $132.65.

According to, Bracelin is a 5-star analyst with an average return of 13.8% and a 71.2% success rate. Bracelin covers the Technology sector, focusing on stocks such as Cornerstone Ondemand, Riverbed Technology, and Medidata Solutions.

Athenahealth has an analyst consensus of Moderate Buy, with a price target consensus of $139.09.

Based on Athenahealth’s latest earnings report for the quarter ending September 30, the company posted quarterly revenue of $305 million and quarterly net profit of $13 million. In comparison, last year the company earned revenue of $288 million and had a net profit of $9.8 million.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

athenahealth, Inc. provides cloud-based business services and mobile applications for medical groups and health systems. It also provides ongoing billing, clinical-related, and other related services to customers. The company offers practice management and electronic health record services.